Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Eat Behav ; 17: 23-6, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25536526

ABSTRACT

During situations that threaten personal adequacy, people high in self-compassion are kind and caring toward themselves, mindful of their distress, and recognize that being imperfect is part of the human experience. Therefore, self-compassion may offset certain disorders (e.g., eating disorders) associated with environmental threats (e.g., thinness-related pressures). In this cross-sectional study, we explored self-compassion's associations with threats involving thinness-related pressures (from friends, family, partners, and media), thin-ideal internalization, and disordered eating among an online sample of 435 U.S. community women. Findings indicated that self-compassion buffered the links from media thinness-related pressure to disordered eating and thin-ideal internalization. Furthermore, higher self-compassion was directly associated with fewer perceived thinness-related pressures, lower thin-ideal internalization, and lower disordered eating. Collectively, these findings add to the growing conceptualization of self-compassion as beneficial to eating behavior and help justify pursuing rigorous longitudinal and clinical examinations of self-compassion as a protective factor of disordered eating.


Subject(s)
Empathy , Feeding and Eating Disorders/psychology , Self Concept , Thinness/psychology , Adolescent , Adult , Cross-Sectional Studies , Female , Humans , Young Adult
2.
ACS Med Chem Lett ; 5(11): 1207-12, 2014 Nov 13.
Article in English | MEDLINE | ID: mdl-25408832

ABSTRACT

Antagonism of αvß6 is emerging as a potential treatment of idiopathic pulmonary fibrosis based on strong target validation. Starting from an αvß3 antagonist lead and through simple variation in the nature and position of the aryl substituent, the discovery of compounds with improved αvß6 activity is described. The compounds also have physicochemical properties commensurate with oral bioavailability and are high quality starting points for a drug discovery program. Compounds 33S and 43E1 are pan αv antagonists having ca. 100 nM potency against αvß3, αvß5, αvß6, and αvß8 in cell adhesion assays. Detailed structure activity relationships with these integrins are described which also reveal substituents providing partial selectivity (defined as at least a 0.7 log difference in pIC50 values between the integrins in question) for αvß3 and αvß5.

SELECTION OF CITATIONS
SEARCH DETAIL
...